adenosine diphosphate has been researched along with mrs 2211 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burns, N; Gerasimovskaya, EV; Liubchenko, GA; Lyubchenko, T; Nijmeh, H; Stenmark, KR; Veo, KD; Woodward, H | 1 |
| Alberti, GS; Alvarez, CL; Davio, C; de Tezanos Pinto, F; Espelt, MV; Incicco, J; Leal Denis, MF; Schwarzbaum, PJ | 1 |
| Hu, J; Jiang, M; Liao, L; Liu, X; Luo, J; Wang, W; Xiang, F | 1 |
3 other study(ies) available for adenosine diphosphate and mrs 2211
| Article | Year |
|---|---|
P2Y1 and P2Y13 purinergic receptors mediate Ca2+ signaling and proliferative responses in pulmonary artery vasa vasorum endothelial cells.
Topics: Adenosine Diphosphate; Animals; Azo Compounds; Calcium; Calcium Channels; Calcium Signaling; Cattle; Cell Proliferation; Cells, Cultured; Endothelium, Vascular; Humans; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Pertussis Toxin; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Purinergic Agonists; Pyridoxal Phosphate; Receptors, Purinergic; Receptors, Purinergic P2Y1; Ribosomal Protein S6; Vasa Vasorum | 2011 |
On the role of ATP release, ectoATPase activity, and extracellular ADP in the regulatory volume decrease of Huh-7 human hepatoma cells.
Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Azo Compounds; Brefeldin A; Carbenoxolone; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Size; Exocytosis; Humans; Hypotonic Solutions; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Protein Synthesis Inhibitors; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2 | 2013 |
Nucleolin down-regulation is involved in ADP-induced cell cycle arrest in S phase and cell apoptosis in vascular endothelial cells.
Topics: Adenosine Diphosphate; Antineoplastic Agents; Aorta; Apoptosis; Azo Compounds; Cell Line; Cell Proliferation; Cisplatin; Dose-Response Relationship, Drug; Endothelial Cells; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Monocytes; Nucleolin; Phosphoproteins; Primary Cell Culture; Proto-Oncogene Proteins c-bcl-2; Purinergic Agonists; Purinergic Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; RNA-Binding Proteins; RNA, Messenger; S Phase Cell Cycle Checkpoints; Signal Transduction; Thionucleotides | 2014 |